Alkermes (ALKS) EPS (Weighted Average and Diluted) (2020 - 2025)
Alkermes (ALKS) has disclosed EPS (Weighted Average and Diluted) for 10 consecutive years, with $0.29 as the latest value for Q4 2025.
- On a quarterly basis, EPS (Weighted Average and Diluted) fell 67.78% to $0.29 in Q4 2025 year-over-year; TTM through Dec 2025 was $1.43, a 33.8% decrease, with the full-year FY2025 number at $1.43, down 35.0% from a year prior.
- EPS (Weighted Average and Diluted) was $0.29 for Q4 2025 at Alkermes, down from $0.49 in the prior quarter.
- In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $1.38 in Q2 2023 to a low of -$0.39 in Q3 2022.
- A 5-year average of $0.32 and a median of $0.39 in 2025 define the central range for EPS (Weighted Average and Diluted).
- Biggest YoY gain for EPS (Weighted Average and Diluted) was 866.67% in 2023; the steepest drop was 147.71% in 2023.
- Alkermes' EPS (Weighted Average and Diluted) stood at $0.77 in 2021, then fell by 23.38% to $0.59 in 2022, then crashed by 147.71% to -$0.28 in 2023, then surged by 419.76% to $0.9 in 2024, then crashed by 67.78% to $0.29 in 2025.
- Per Business Quant, the three most recent readings for ALKS's EPS (Weighted Average and Diluted) are $0.29 (Q4 2025), $0.49 (Q3 2025), and $0.52 (Q2 2025).